Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Colorectal cancer screening.

J F Helm1, R S Sandler

  • 1Department of Medicine, University of South Florida, Tampa, USA.

The Medical Clinics of North America
|December 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CYP2C19 Genotype Is Not Associated With the Risk of Microscopic Colitis.

Gastro hep advances·2023
Same author

The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease.

Alimentary pharmacology & therapeutics·2017
Same author

Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.

Alimentary pharmacology & therapeutics·2013
Same author

Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.

Alimentary pharmacology & therapeutics·2012
Same author

Statistical strategies to improve the efficiency of molecular studies of colorectal cancer prognosis.

British journal of cancer·2008
Same author

Histamine receptor antagonists and incident colorectal adenomas.

Alimentary pharmacology & therapeutics·2005

Colorectal cancer screening, including fecal occult blood testing and adenoma removal, is proven to reduce mortality and incidence. Screening guidelines should be tailored to individual risk factors, with higher-risk individuals needing more intensive surveillance.

Area of Science:

  • Oncology
  • Gastroenterology
  • Preventive Medicine

Background:

  • Colorectal cancer (CRC) poses a significant public health challenge in the US, causing over 130,000 new cases and 55,000 deaths annually.
  • Evidence supports that colorectal cancer screening can decrease mortality and incidence.
  • Screening strategies should be individualized based on risk assessment.

Purpose of the Study:

  • To summarize the evidence for colorectal cancer screening effectiveness.
  • To emphasize the importance of risk-stratified screening protocols.

Main Methods:

  • Review of existing evidence on fecal occult blood testing (FOBT) and adenoma removal.
  • Analysis of risk factors influencing colorectal cancer development and outcomes.

Related Experiment Videos

Main Results:

  • Fecal occult blood testing demonstrates efficacy in reducing colorectal cancer mortality.
  • Removal of benign adenomas is associated with a decrease in colorectal cancer incidence.
  • Personal or family history significantly elevates an individual's risk for colorectal cancer.

Conclusions:

  • Screening for colorectal cancer is a vital strategy for reducing morbidity and mortality.
  • Intensified screening protocols are recommended for individuals with a higher risk profile, including those with a personal or family history of colorectal cancer.
  • Risk-based screening ensures optimal resource allocation and patient outcomes.